SEARCH

SEARCH BY CITATION

References

  • Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin JP, Järvinen H, Powell SM, Jen J, Hamilton SR, Petersen GM, Kinzler KW, Vogelstein B, de la Chapelle A. 1993. Clues to the pathogenesis of familial colorectal cancer. Science 260:812816.
  • Chan PA, Duraisamy S, Miller PJ, Newell JA, McBride C, Bond JP, Raevaara T, Ollila S, Nyström M, Grimm AJ, Christodoulou J, Oetting WS, Greenblatt MS. 2007. Interpreting missense variants: comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and Tyrosinase (TYR). Hum Mutat 28:683693.
  • Chang DK, Ricciardiello L, Goel A, Chang CL, Boland CR. 2000. Steady-state regulation of the human DNA mismatch repair system. J Biol Chem 275:1842418431.
  • Chao EC, Velasquez JL, Witherspoon MSL, Rozek LS, Peel D, Ng P, Gruber SB, Watson P, Rennert G, Anton-Culver H, Lynch H, Lipkin SM. 2008. Accurate classification of MLH1/MSH2 missense variants with multivariate analysis of protein polymorphisms-mismatch repair (MAPP-MMR). Hum Mutat 29:852860.
  • Christensen LL, Kariola R, Korhonen MK, Wikman FP, Sunde L, Gerdes AM, Okkels H, Brandt CA, Bernstein I, Hansen TVO, Hagemann-Madsen R, Andersen CL, Nyström M, Orntoft TF. 2009. Functional characterisation of rare missense mutations in MLH1 and MSH2 identified in Danish colorectal cancer patients. Familial Cancer 8:489500.
  • Christensen LL, Madsen BE, Wikman FP, Wiuf C, Koed K, Tjønneland A, Olsen A, Syvänen AC, Andersen CL, Orntoft TF. 2008. The association between genetic variants in hMLH1 and hMSH2 and the development of sporadic colorectal cancer in the Danish population. BMC Med Genet 9:52.
  • Couch FJ, Rasmussen LJ, Hofstra R, Monteiro ANA, Greenblatt MS, de Wind N, IARC unclassified variants working group. 2008. Assessment of functional effects of unclassified genetic variants. Hum Mutat 29:13141326.
  • Cyr JL, Heinen CD. 2008. Hereditary cancer-associated missense mutations in hMSH6 uncouple ATP hydrolysis from DNA mismatch binding. J Biol Chem 283:3164131648.
  • Goldgar DE, Easton DF, Byrnes GB, Spurdle AB, Iversen ES, Greenblatt MS. 2008. Genetic evidence and integration of various data sources for classifying uncertain variants into a single model. Hum Mutat 29:12651272.
  • Guerrette S, Acharya S, Fishel R. 1999. The interaction of the human MutL homologues in hereditary nonpolyposis colon cancer. J Biol Chem 274:63366341.
  • Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakawaga H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D, Lockman J, Comeras I, de la Chapelle A. 2005. Screening for the Lynch Syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352:18511860.
  • Hendriks YMC, Wagner A, Morreau H, Menko F, Stormorken A, Quehenberger F, Sandkuijl L, Møller P, Genuardi M, Van Houwelingen H, Tops C, Van Puijenbroek M, Verkuijlen P, Kenter G, Van Mil A, Meijers-Heijboer H, Tan GB, Breuning MH, Fodde R, Winjen JT, Bröcker-Vriends AHJT, Vasen H. 2004. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 127:1725.
  • Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM, Kolodner R. 1997. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57:808811.
  • Kariola R, Hampel H, Frankel WL, Raevaara TE, de la Chapelle A, Nyström-Lahti M. 2004. MSH6 missense mutations are often associated with no or low cancer susceptibility. Br J Cancer 91:12871292.
  • Kariola R, Otway R, Lönnqvist KE, Raevaara TE, de la Chapelle A, Nyström-Lahti M. 2003. Two mismatch repair gene mutations found in a colon cancer patient—which one is pathogenic? Hum Genet 112:105109.
  • Kariola R, Raevaara TE, Lönnqvist KE, Nyström-Lahti M. 2002. Functional analysis of MSH6 mutations linked to kindreds with putative hereditary non-polyposis colorectal cancer syndrome. Hum Mol Genet 11:13031310.
  • Kohonen-Corish M, Ross VL, Doe WF, Kool DA, Edkins E, Faragher I, Wijnen J, Khan PM, Macrae F, St John DL. 1996. RNA-based mutation screening in hereditary nonpolyposis colorectal cancer. Am J Hum Genet 59:818824.
  • Kondo E, Suzuki H, Horii A, Fukushige S. 2003. A yeast two-hybrid assay provides a simple way to evaluate the vast majority of hMLH1 germ-line mutations. Cancer Res 63:33023308.
  • Lynch HT, de la Chapelle A. 1999. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 36:801818.
  • Mangold E, Pagenstecher C, Friedl W, Fischer HP, Merkelbach-Bruse S, Ohlendorf M, Friedrichs N, Aretz S, Buettner R, Propping P, Mathiak M. 2005. Tumours from MSH2 mutation carriers show loss of MSH2 expression but many tumours from MLH1 carriers exhibit weak positive MLH1 staining. J Pathol 207:385395.
  • Ng PC, Henikoff S. 2001. Predicting deleterious amino acid substitutions. Genome Res 11:863874.
  • Nyström-Lahti M, Perrera C, Räschle M, Panyushkina-Seiler E, Marra G, Curci A, Ouaresima B, Constanzo F, D'Urso M, Venuta S, Jiricny J. 2002. Functional analysis of MLH1 mutations linked to hereditary nonpolyposis colon cancer. Genes Chromosomes Cancer 33:160167.
  • Nyström-Lahti M, Holmberg M, Fidalgo P, Salovaara R, de la Chapelle A, Jiricny J, Peltomäki P. 1999. Missense and nonsense mutations in codon 659 of MLH1 cause aberrant splicing of messenger RNA in HNPCC kindreds. Genes Chromosomes Cancer 26:372375.
  • Ollila S, Dermadi Bebek D, Jiricny J, Nyström M. 2008. Mechanisms of pathogenicity in human MSH2 missense mutants. Hum Mutat 29:13551363.
  • Ollila S, Sarantaus L, Kariola R, Chan P, Hampel H, Holinski-Feder E, Macrae F, Kohonen-Corish M, Gerdes AM, Peltomäki P, Mangold E, de la Chapelle A, Greenblatt M, Nyström M. 2006. Pathogenicity of MSH2 missense mutations is typically associated with impaired repair capability of the mutated protein. Gastroenterology 131:14081417.
  • Plon SE, Eccles DM, Easton D, Foulkes WD, Genuardi M, Greenblatt MS, Hogervorst FBL, Hoogerbrugge N, Spurdle AB, Tavtigian SV, IARC Unclassified Genetic Variants Working Group. 2008. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 29:12821291.
  • Raevaara TE, Korhonen MK, Lohi H, Hampel H, Lynch E, Lönnqvist KE, Holinski-Feder E, Sutter C, McKinnon W, Duraisamy S, Gerdes AM, Peltomäki P, Kohonen-Corish M, Mangold E, Macrae F, Greenblatt M, de la Chapelle A, Nyström M. 2005. Functional significance and clinical phenotype of nontruncating mismatch repair variants of MLH1. Gastroenterology 129:537549.
  • Raevaara TE, Vaccaro C, Abdel-Rahman WM, Mocetti E, Bala S, Lönnqvist KE, Kariola R, Lynch HT, Peltomäki P, Nyström-Lahti M. 2003. Pathogenicity of the hereditary colorectal cancer mutation hMLH1 del616 linked to shortage of the functional protein. Gastroenterology 125:501509.
  • Stone EA, Sidow A. 2005. Physiochemical constraint violation by missense substitutions mediates impairment of protein function and disease severity. Genome Res 15:978986.
  • Tavtigian SV, Byrnes GB, Goldgar DE, Thomas A. 2008a. Classification of rare missense substitutions, using risk surfaces, with genetic-and molecular-epidemiology applications. Hum Mutat 29:13421354.
  • Tavtigian SV, Greenblatt MS, Lesueur F. 2008b. In silico analysis of missense substitutions using sequence-alignment based methods. Hum Mutat 29:13271336.
  • Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomäki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HFA, Hawk ET, Barrett JC, Freedman AN, Srivastava S. 2004. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261268.
  • Vasen HFA, Mecklin J-P, Khan PM, Lynch HT. 1991. The International Collaborative Group on Hereditary Non-polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34:424425.
  • Vasen HFA, Watson P, Mecklin J-P, Lynch HT, the ICG-HNPCC. 1999. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology 116:14531456.